[1] 张文娟,方开云.不同剂量右美托咪定对神经外科手术患者全身麻醉恢复质量的影响[J].贵阳医学院学报,2016,41(1):99-102.
[2] 左圣慧,高红芝.微血管减压术治疗老年三叉神经痛56例及其手术配合[J].医学临床研究,2013,30(9):1833-1834.
[3] 宗强,王立江,韩光良,等.微骨孔乙状窦后入路显微血管减压术治疗常见颅神经疾病的临床研究(附211例报道)[J].中华神经医学杂志,2012,11(9):923-927.
[4] Sulaiman S,Karthekeyan RB,Vakamudi M,et al. The effects of dexme-detomidine on attenuation of stress response to endotracheal intubation in patie-nts undergoing elective off-pump coronary artery bypass grafting[J].Ann Card Anaesth,2012,15(1):39-43.
[5] Panzer O, Moitra V, Sladen RN. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists[J].Crit Care Clin, 2009,25(3): 451-469.
[6] 闫诺,杨程.右美托咪定在三叉神经痛合并高血压微血管减压术麻醉中的应用[J].新乡医学院学报,2014,31(12):1011-1014.
[7] Lee JQ, Oh SH, Na SI, et al. The effect of initial serum neuron-specific-enolase level on clinical outcome in acute carotid artery territory infarction[J]. Yonsei Med, 2002, 43(3):357-362.
[8] 李新春,戚岩,赵建辉,等.不同剂量右美托咪定对颅脑损伤患者围术期脑氧代谢的影响[J].河北医药,2013,35(3):356-357.
(本文编辑:王沪湘) [收稿日期] 2017-04-13
|
2017, Vol. 34 
